Selames 60 mg spot-on solution for cats 7.6–10.0 kg

Land: Irland

Sprog: engelsk

Kilde: HPRA (Health Products Regulatory Authority)

Aktiv bestanddel:

Selamectin

Tilgængelig fra:

Krka, d.d., Novo mesto

ATC-kode:

QP54AA05

INN (International Name):

Selamectin

Dosering:

60 mg/pipette

Lægemiddelform:

Spot-on solution

Recept type:

POM: Prescription Only Medicine as defined in relevant national legislation

Terapeutisk område:

selamectin

Autorisation status:

Authorised

Autorisation dato:

2018-12-21

Produktets egenskaber

Health Products Regulatory Authority
20 April 2021
CRN00C74F
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Selames 60 mg spot-on solution for cats 7.6–10.0 kg
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
​
Each 1 ml pipette contains:
​
​
​
ACTIVE SUBSTANCE:
​
​
​
Selamectin
​60
​
mg
​
EXCIPIENTS:
​
​
​
Butylhydroxytoluene (E321)
​0.8
​
mg
​
For the full list of excipients, see section 6.1.
​
​
3 PHARMACEUTICAL FORM
Spot-on solution.
Clear, colourless to yellow to brown solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cats (7.6–10.0 kg)
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES

TREATMENT AND PREVENTION OF FLEA INFESTATIONS
caused by _Ctenocephalides _spp. for one month following a single
administration. This is as a result of the
adulticidal, larvicidal and ovicidal properties of the product. The
product is ovicidal for 3 weeks after administration.
Through a reduction in the flea population, monthly treatment of
pregnant and lactating animals will also aid in
the prevention of flea infestations in the litter up to seven weeks of
age. The product can be used as part of a
treatment strategy for flea allergy dermatitis and through its
ovicidal and larvicidal action may aid in the control of
existing environmental flea infestations in areas to which the animal
has access.

TREATMENT OF EAR MITES (_Otodectes cynotis_).

TREATMENT OF BITING LICE INFESTATIONS (_Felicola subrostratus_)

TREATMENT OF ADULT ROUNDWORMS (_Toxocara cati_)

TREATMENT OF ADULT INTESTINAL HOOKWORMS (_Ancylostoma tubaeforme_)

PREVENTION OF HEARTWORM DISEASE caused by _Dirofilaria immitis _with
monthly administration.
4.3 CONTRAINDICATIONS
Do not use in animals under 6 weeks of age.
Do not use in cats that are suffering from concomitant disease, or are
debilitated and underweight (for size and age).
Do not use in cases of hypersensitivity to the active substance or to
any of the excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPEC